Endothelial induced EMT in breast epithelial cells with stem cell properties

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sigurdsson, Valgardur ^a,b   Hilmarsdottir, Bylgja ^a,b   Sigmundsdottir, Hekla ^a,b   Fridriksdottir, Agla J R ^c   Ringnér, Markus ^d   Villadsen, Rene ^c   Borg, Ake ^d   Agnarsson, Bjarni A ^b   Petersen, Ole William ^c   Magnusson, Magnus K ^a,b   Gudjonsson, Thorarinn ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; HERMES ANTIGEN; KERATIN; NERVE CELL ADHESION MOLECULE; SCATTER FACTOR; UVOMORULIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER GROWTH; CANCER STEM CELL; CELL ANCHORAGE; CELL IMMORTALIZATION; CELL LEVEL; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MESENCHYME CELL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION; CELL CULTURE; CELL DEDIFFERENTIATION; CELL LINE; CYTOLOGY; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; IMMUNOCHEMISTRY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL DEDIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST GROWTH FACTORS; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOCHEMISTRY; NEOPLASTIC STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80052455345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023833     Document Type: Article

References (52)

1. De Wever O, Pauwels P, De Craene B, Sabbah M, Emami S, et al. (2008) Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 130: 481-494.
2. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, et al. (2007) Epithelial- mesenchymal and mesenchymal- epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383.
3. Moustakas A, Heldin CH, (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520.
4. Peinado H, Olmeda D, Cano A, (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428.
5. Zeisberg M, Neilson EG, (2009) Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437.
6. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
7. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, et al. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3: e2888.
8. Polyak K, Weinberg RA, (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
9. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68: 989-997.
10. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, et al. (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495.
11. Mahler-Araujo B, Savage K, Parry S, Reis-Filho JS, (2008) Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol 61: 615-620.
12. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
13. Ishihara A, Tsuda H, Kitagawa K, Yoneda M, Shiraishi T, (2009) Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features. Breast Cancer 16: 179-185.
14. Yehiely F, Moyano JV, Evans JR, Nielsen TO, Cryns VL, (2006) Deconstructing the molecular portrait of basal-like breast cancer. Trends Mol Med 12: 537-544.
15. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, et al. (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 98: 10356-10361.
16. Franci C, Takkunen M, Dave N, Alameda F, Gomez S, et al. (2006) Expression of Snail protein in tumor-stroma interface. Oncogene 25: 5134-5144.
17. Ronnov-Jessen L, Bissell MJ, (2009) Breast cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 15: 5-13.
18. Weaver V, Fischer A, OW P, Bissell M, (1996) The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unigue human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 74: 833-851.
19. May CD, Sphyris N, Evans KW, Werden SJ, Guo W, et al. (2011) Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res 13: 202.
20. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, et al. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340.
21. Yin T, Li L, (2006) The stem cell niches in bone. J Clin Invest 116: 1195-1201.
22. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS, (2001) Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294: 559-563.
23. Lammert E, Cleaver O, Melton D, (2001) Induction of pancreatic differentiation by signals from blood vessels. Science 294: 564-567.
24. Shekhar MP, Werdell J, Tait L, (2000) Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res 60: 439-449.
25. Sigurdsson V, Fridriksdottir AJ, Kjartansson J, Jonasson JG, Steinarsdottir M, et al. (2006) Human breast microvascular endothelial cells retain phenotypic traits in long-term finite life span culture. In Vitro Cell Dev Biol Anim 42: 332-340.
26. Ingthorsson S, Sigurdsson V, Fridriksdottir AJ, Jonasson JG, Kjartansson J, et al. (2010) Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture. BMC Res Notes 3: 184.
27. Franzdottir SR, Axelsson IT, Arason AJ, Baldursson O, Gudjonsson T, et al. (2010) Airway branching morphogenesis in three dimensional culture. Respir Res 11: 162.
28. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jessen L, Bissell MJ, et al. (2002) Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev 16: 693-706.
29. Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, et al. (2007) Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol 177: 87-101.
30. Chernousov MA, Fogerty FJ, Koteliansky VE, Mosher DF, (1991) Role of the I-9 and III-1 modules of fibronectin in formation of an extracellular fibronectin matrix. J Biol Chem 266: 10851-10858.
31. Petersen OW, Nielsen HL, Gudjonsson T, Villadsen R, Rank F, et al. (2003) Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 162: 391-402.
32. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
33. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
34. Sabbah M, Emami S, Redeuilh G, Julien S, Prevost G, et al. (2008) Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11: 123-151.
35. Leroy P, Mostov KE, (2007) Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell 18: 1943-1952.
36. Greenberg S, Rugo HS, (2010) Triple-negative breast cancer: role of antiangiogenic agents. Cancer J 16: 33-38.
37. Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F, (2009) Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles. Histopathology 55: 594-599.
38. Uzzan B, Nicolas P, Cucherat M, Perret GY, (2004) Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 64: 2941-2955.
39. Miyashita M, Ishida T, Ishida K, Tamaki K, Amari M, et al. (2010) Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates. Virchows Arch.
40. Linderholm BK, Hellborg H, Johansson U, Elmberger G, Skoog L, et al. (2009) Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol 20: 1639-1646.
41. Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI, (2010) The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol.
42. Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, et al. (2007) Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 26: 385-394.
43. Gastaldi S, Comoglio PM, Trusolino L, (2010) The Met oncogene and basal-like breast cancer: another culprit to watch out for? Breast Cancer Res 12: 208.
44. Chu SH, Feng DF, Ma YB, Zhu ZA, Zhang H, et al. (2009) Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1. Mol Biol Rep 36: 1967-1975.
45. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, et al. (2003) Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3: 347-361.
46. Elenbaas B, Weinberg RA, (2001) Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 264: 169-184.
47. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, et al. (2009) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28: 4022-4033.
48. Santisteban M, Reiman JM, Asiedu MK, Behrens MD, Nassar A, et al. (2009) Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 69: 2887-2895.
49. Lee GY, Kenny PA, Lee EH, Bissell MJ, (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4: 359-365.
50. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, et al. (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115: 39-50.
51. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 101: 4966-4971.
52. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, et al. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25: 629-642.